The Effect of Two Dietary Interventions on the Symptomatic Control of People Living With Anxiety Disorders.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

35 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-10-15

Study Completion Date

2024-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomised controlled trial will evaluate the effect of a ketogenic diet vs a conventional diet on the symptoms of patients living with anxiety disorders using a validate self-reported inventory.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Mechanism of Ketogenic Diet-Induced Hypercholesterolemia

NCT06894004

Hypercholesterolemia and Hyperlipidemia

RECRUITING NA

Dietary Intervention Methods for Clinical Trials

NCT00005686

Cardiovascular Diseases Heart Diseases Obesity

COMPLETED

Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy

NCT02694094

Hypercholesterolemia Carotid Intimal Medial Thickness 1 Seizure +5 more

ACTIVE_NOT_RECRUITING

Long COVID-19 Syndrome Lifestyle Intervention Study

NCT05836402

Long COVID-19 Syndrome

COMPLETED NA

Therapeutic Diets in Alzheimer's Disease

NCT03860792

Alzheimer Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

It has been theorized that ketogenic diet could improve symptom control in patients living with anxiety disorders. Animal models support this hypothesis but to this date, studies in humans are lacking.

The investigators will randomise patients with a confirmed diagnosis of anxiety disorders to follow a ketogenic diet (\<50 grs of carbohydrate per day) or a conventional diet (50% carbohydrate, 30% lipids, 20% protein) for one month.

Symptom control will be assessed weekly using Beck's inventory for Anxiety. Diet adherence will be measured using standardised food frequency logs and acetoacetate urine strips.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anxiety Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomised controlled trial

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Conventional diet

Conventional diet. (50% carbohydrate, 30% lipids, 20% protein). Current dietary recommendations from official guidelines will be reinforced.

Group Type ACTIVE_COMPARATOR

Diet

Intervention Type OTHER

\<50 grams of total carbohydrates per day. Monosaturated fats consumption will be encouraged over saturated fats.

Ketogenic diet

Tailored ketogenic diet. Participants will be allowed to chose their meals as long as they consume less than 50gr of carbohydrates per day.

Group Type EXPERIMENTAL

Diet

Intervention Type OTHER

\<50 grams of total carbohydrates per day. Monosaturated fats consumption will be encouraged over saturated fats.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Diet

\<50 grams of total carbohydrates per day. Monosaturated fats consumption will be encouraged over saturated fats.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with a confirmed diagnosis of Anxiety Disorder by Psychiatrist.

Exclusion Criteria

* Patients with the diagnosis of drug abuse, cognitive impairment or dementia, porphyria, carnitine translocase deficiency and carnitine palmitoyl transferase deficiency.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No